Research project
Myeloma UK Trials and Innovation At Leeds
- Start date: 2026
- End date: 2029
- Funder: Myeloma UK
- Value: £494,999.98
- Partners and collaborators: Myeloma UK
- Primary investigator: Professor Sarah R Brown
- Co-investigators: Dr Chris Parrish
Description
The MyeTRIAL (Myeloma UK TRials and Innovation At Leeds) Partnership puts patients in the driving seat of improving myeloma treatment and care. It is led by Dr Chris Parrish, consultant haemetologist at Leeds Teaching Hospitals NHS Trust and Associate Professor at the University of Leeds.
Myeloma UK are proud to work alongside the University of Leeds Clinical Trials Research Unit (CTRU), bringing together our patient insight and expertise with the CTRU team’s incredible track record in myeloma trials. Together, we help to shape myeloma trials that create the change people living with myeloma need most.